Gold, L. S., M. G. Lebwohl, N. Bhatia, T. Lin, and R. Pillai. “Long-Term Management of Moderate-to-Severe Plaque Psoriasis: Maintenance of Treatment Success Following Cessation of Fixed Combination Halobetasol Propionate 0.01% And Tazarotene 0.045% (HP/TAZ) Lotion”. SKIN The Journal of Cutaneous Medicine, vol. 3, Nov. 2019, p. S31, doi:10.25251/skin.3.supp.31.